Miao Xu
10Patents
3h-index
19Co-inventors
49Inventor score
Filing activity: Jun 12, 2017 → Jun 28, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10555942B2 | Emetine compounds for treatment and prevention of flavivirus infection | Emerging Cross-Sectional Technologies | 7 | Active |
| US11096927B2 | Anti-flavivirus compounds and methods of use | Emerging Cross-Sectional Technologies | 5 | Active |
| US11471443B2 | Anti-flavivirus compounds and methods of use | Emerging Cross-Sectional Technologies | 4 | Active |
| US11020422B2 | Cyclodextrin for the treatment of lysosomal storage diseases | Physics | 1 | Active |
| US11850236B2 | Method for inhibiting Zika virus infection | Emerging Cross-Sectional Technologies | 0 | Active |
| US11207315B2 | Emetine compounds for treatment and prevention of flavivirus infection | Emerging Cross-Sectional Technologies | 0 | Active |
| US10940188B2 | Compounds and methods for treatment and prevention of Flavivirus infection | Emerging Cross-Sectional Technologies | 0 | Active |
| US11779570B2 | Method for inhibiting dengue virus infection | Emerging Cross-Sectional Technologies | 0 | Active |
| US11878004B2 | Method for inhibiting Zika virus infection | Emerging Cross-Sectional Technologies | 0 | Active |
| US11903929B2 | Method for inhibiting dengue virus infection | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.